Clinical Trials
30
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
- Conditions
- Poliomyelitis
- Interventions
- Biological: Novel Oral Polio Vaccine Type 2 (nOPV2)Biological: Placebo (Sterile Water)
- First Posted Date
- 2025-03-26
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- PATH
- Target Recruit Count
- 675
- Registration Number
- NCT06895486
- Locations
- 🇵🇦
Cevaxin - 24 de Diciembre, Panama, Panama
🇵🇦Cevaxin - Ave. México, Panama, Panama
🇵🇦Cevaxin - Chorrera, Panama, Panama
Infant Malaria Vaccine Schedule Optimization
- Conditions
- Malaria Vaccines
- Interventions
- Biological: R21 Matrix-M (R21/MM) Malaria VaccineBiological: PlaceboBiological: Hexavalent VaccineBiological: Rotavirus, Live Attenuated (Oral) VaccineBiological: Meningococcal A conjugate vaccine
- First Posted Date
- 2025-03-17
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- PATH
- Target Recruit Count
- 1200
- Registration Number
- NCT06879327
- Locations
- 🇧🇫
Institut de Recherche en Science de la Santé (IRSS), Bobo-Dioulasso, Burkina Faso
🇧🇫Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso
MaCRA Part B in Nigeria
- Conditions
- Malaria
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- PATH
- Target Recruit Count
- 350
- Registration Number
- NCT06805110
MaCRA Part B in Côte d'Ivoire
- Conditions
- Malaria
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- PATH
- Target Recruit Count
- 231
- Registration Number
- NCT06804902
- Locations
- 🇨🇮
Health facilities in selected districts, Cities In Selected Districts, Côte D'Ivoire
News
Bharat Biotech and GSK Pledge to Cut Malaria Vaccine Price by More Than Half to Under $5 by 2028
Bharat Biotech and GSK announced they will reduce the price of the world's first malaria vaccine RTS,S by more than half to less than $5 per dose by 2028.
Microneedle Technology Emerges as Game-Changer for Targeted Drug Delivery and Vaccine Administration
Microneedle technology is revolutionizing drug delivery by offering a minimally invasive alternative to traditional injection methods, with applications spanning vaccines, biologics, and gene therapies.